|
Myomo, Inc. (MYO) Valoración de DCF
US | Healthcare | Medical - Devices | AMEX
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Myomo, Inc. (MYO) Bundle
¡Simplifique la valoración de Myomo, Inc. (MYO) con esta calculadora DCF personalizable! Con el Real Myomo, Inc. (MYO) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Myomo, Inc. (MYO) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.8 | 7.6 | 13.9 | 15.6 | 19.2 | 29.6 | 45.7 | 70.4 | 108.4 | 167.0 |
| Revenue Growth, % | 0 | 97.6 | 82.72 | 12.26 | 23.7 | 54.07 | 54.07 | 54.07 | 54.07 | 54.07 |
| EBITDA | -10.7 | -11.2 | -9.9 | -10.1 | -8.1 | -22.5 | -34.6 | -53.3 | -82.1 | -126.5 |
| EBITDA, % | -278.81 | -148.17 | -71.68 | -65.12 | -41.93 | -75.75 | -75.75 | -75.75 | -75.75 | -75.75 |
| Depreciation | .1 | .1 | .3 | .5 | .5 | .7 | 1.1 | 1.8 | 2.7 | 4.2 |
| Depreciation, % | 2.48 | 1.43 | 2.42 | 3.49 | 2.69 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| EBIT | -10.8 | -11.3 | -10.3 | -10.7 | -8.6 | -23.0 | -35.4 | -54.5 | -84.0 | -129.4 |
| EBIT, % | -281.29 | -149.61 | -74.1 | -68.61 | -44.62 | -77.47 | -77.47 | -77.47 | -77.47 | -77.47 |
| Total Cash | 4.5 | 12.2 | 15.5 | 5.3 | 8.9 | 22.6 | 34.8 | 53.5 | 82.5 | 127.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .4 | .9 | 2.0 | 1.9 | 2.4 | 3.7 | 5.7 | 8.7 | 13.4 | 20.7 |
| Account Receivables, % | 11.06 | 12.2 | 14.15 | 12.19 | 12.38 | 12.39 | 12.39 | 12.39 | 12.39 | 12.39 |
| Inventories | .4 | .7 | .8 | 1.4 | 1.8 | 2.7 | 4.1 | 6.3 | 9.8 | 15.0 |
| Inventories, % | 11.45 | 9.32 | 5.83 | 9 | 9.37 | 9 | 9 | 9 | 9 | 9 |
| Accounts Payable | .5 | .2 | .7 | .6 | 1.1 | 1.7 | 2.6 | 4.0 | 6.2 | 9.5 |
| Accounts Payable, % | 11.73 | 2.38 | 5.22 | 3.66 | 5.58 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 |
| Capital Expenditure | -.1 | .0 | -.3 | -.1 | -.1 | -.3 | -.5 | -.8 | -1.3 | -1.9 |
| Capital Expenditure, % | -1.35 | -0.60332 | -2.36 | -0.71868 | -0.75783 | -1.16 | -1.16 | -1.16 | -1.16 | -1.16 |
| Tax Rate, % | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 |
| EBITAT | -10.7 | -11.8 | -10.4 | -10.7 | -8.8 | -22.9 | -35.3 | -54.4 | -83.9 | -129.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -11.1 | -12.8 | -10.9 | -11.0 | -8.8 | -24.1 | -37.2 | -57.4 | -88.4 | -136.1 |
| WACC, % | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 | 11.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -227.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -139 | |||||||||
| Terminal Value | -1,422 | |||||||||
| Present Terminal Value | -815 | |||||||||
| Enterprise Value | -1,042 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | -1,036 | |||||||||
| Diluted Shares Outstanding, MM | 29 | |||||||||
| Equity Value Per Share | -35.12 |
What You Will Receive
- Pre-Filled Financial Model: Myomo’s actual data allows for accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other critical metrics.
- Real-Time Calculations: Automatic updates provide immediate insights as you adjust parameters.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Flexible and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.
Key Features
- 🔍 Real-Life MYO Financials: Pre-filled historical and projected data for Myomo, Inc. (MYO).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Myomo’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Myomo’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Open the Template: Download and open the Excel file containing Myomo, Inc.'s (MYO) preloaded data.
- 2. Edit Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV.
- 4. Test Scenarios: Evaluate various forecasts to explore different valuation outcomes.
- 5. Use with Confidence: Present professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Myomo, Inc. (MYO)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Myomo, Inc. (MYO).
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Myomo's intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable starting points for analysis.
- High-Quality Standards: Perfect for financial analysts, investors, and business consultants focused on Myomo, Inc. (MYO).
Who Should Use This Product?
- Healthcare Professionals: Evaluate the financial performance and potential of Myomo, Inc. (MYO) for investment decisions.
- Corporate Finance Teams: Assess valuation models to inform strategic planning and resource allocation.
- Consultants and Advisors: Deliver precise valuation assessments for clients interested in Myomo, Inc. (MYO).
- Students and Educators: Utilize real-time market data to enhance learning in financial analysis and modeling.
- Investors in Medical Technology: Gain insights into the valuation methodologies applied to companies like Myomo, Inc. (MYO).
What the Myomo, Inc. (MYO) Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations specific to Myomo, Inc. (MYO).
- Real-World Data: Myomo's historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into Myomo, Inc. (MYO).
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results tailored to Myomo, Inc. (MYO).